Patents
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
05/2008
05/14/2008CN101177442A 2'-fluorine-4'-substituted-nucleosides analog, preparation method and uses thereof
05/14/2008CN100387237C Beta-L-2'deoxy-nucleosides for the treatment of hepatitis B
05/13/2008US7371737 E.g., 2-nitro-6-trifluoromethyl-9-methyl purine; 2-morpholinyl-6-fluoromethyl-9- beta -D-ribofuranosyl purine; 6-trifluoromethyl-9-methyl-2-benzylamino purine; intermediates; preparation
05/13/2008US7371524 Substituted azaporphyrins as fluorescence labels
05/13/2008CA2370535C Replica amplification of nucleic acid arrays
05/13/2008CA2293470C Benzimidazole derivatives
05/13/2008CA2270211C Process for producing uridine diphosphate-n-acetylglucosamine
05/08/2008WO2008052722A2 Use of ribavirin-conjugates as an anti-viral drug
05/08/2008WO2008032103A3 Process for the preparation of an (rp)-8-substituted camps
05/08/2008WO2008007153A3 Antiviral compounds
05/08/2008WO2004092191A8 Polymeric oligonucleotide prodrugs
05/08/2008US20080108546 Novel Human Card-Only Protein That Inhibits Pro-Il-1 Beta Maturation
05/08/2008DE202005021489U1 Zusammmensetzung für die Synthese von phosphitylierten Verbindungen A composition as for the synthesis of compounds phosphitylated
05/07/2008EP1468114B1 Late-pcr
05/07/2008EP1412369B1 Process for preparing purine nucleosides
05/07/2008CN101175763A Phosphoramidate derivatives of nucleoside compounds for use in the treatment of cancer
05/07/2008CN101172993A 2'-c-methyl-3'-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
05/07/2008CN101172992A Modified 2' and 3'-nucleoside prodrugs for treating flaviviridae infections
05/06/2008US7368551 De novo DNA cytosine methyltransferase genes, polypeptides and uses thereof
05/06/2008US7368549 Modified oligonucleotides with substituted pyrazolo[3,4-d]pyrimidines and pyrimidines; minor groove binders, reporter groups; mismatch discrimination at high temperatures
05/06/2008US7368439 Prevention or treatment of disorders modulated by P2Y receptors such as type 2 diabetes, cystic fibrosis and cancer
05/06/2008US7368438 Non-nucleotide compositions and method for inhibiting platelet aggregation
05/06/2008US7368437 Bicyclic heterocycles, processes for their preparation and their use as herbicides and pharmaceutical agents
05/06/2008US7368239 Reacting DNA with magnesium bisulfite; kits
05/06/2008US7368236 Methods of producing nucleic acid ligands
05/02/2008WO2008051285A2 Methods and compositions for detecting fungi and mycotoxins
05/02/2008WO2008049644A1 Thymidine analogs for imaging
05/01/2008US20080103186 Novel crystalline forms of an antiviral benzimidazole compound
05/01/2008US20080103115 Phosphonate compounds
05/01/2008US20080103110 Water soluble prodrugs comprising therapeutics coupled via metabolically cleavable ester bond to proteins; extended blood half life; cancer, inflammation, infection, pain
05/01/2008US20080103088 Combating disorders affecting mitochondrial oxidative phosphorylation system by allotopic expression of the cyanide-insensitive alternative oxidase (AOX) in human cells; polynucleotide obtained from Mollusca, Nematoda and Chordata; metabolic, cardiovascular, genetic, and nervous system disorders
05/01/2008US20080102519 Apparatus and method for preparative scale purification of nucleic acids
04/2008
04/30/2008EP1916003A1 Thymidine analogs for imaging
04/30/2008CN101168554A Method for preparing 18F-FLT
04/30/2008CN100385009C Method of preparing a guanosine-group compound and an intermediate thereof
04/29/2008US7365188 Admixing 5-fluorocytosine with silylating agent in presence of acid catalyst, admixing with 2,3-diprotected-5-deoxy furanoside, acylating, then deblocking/deprotecting
04/29/2008US7365178 Acyl-nucleotide probes and methods of their synthesis and use in proteomic analysis
04/29/2008US7365132 For the synthesis of polymers which are useful as supports in solid phase organic synthesis
04/29/2008CA2181474C Process for the production of asymmetrical phosphoric acid diesters
04/29/2008CA2177952C Nucleosides and oligonucleotides containing boron clusters
04/24/2008CA2666555A1 Synthesis and compositions of nucleic acids comprising 2'-terminator nucleotides
04/23/2008EP1914238A2 Methods for measuring physical characteristics of nucleic acids by microscope imaging
04/23/2008EP1914237A2 Phosphonate ester antiviral compounds
04/23/2008CN101166750A Therapeutic furopyrimidines and thienopyrimidines
04/23/2008CN101164543A Acyl pseudopeptides bearing a functionalised auxiliary spacer
04/23/2008CN100383128C Ramification of N-carbethoxy cytosine and preparation method and application
04/22/2008US7361759 Method for producing L-biopterin
04/22/2008US7361747 Nucleotide sequence containing genome sequence; for therapy, diagnosis; chimeric or genetic engineered viruse which codes nucleotide sequence
04/22/2008US7361746 Methods and compositions for detection of Mycobacterium avium complex species
04/22/2008CA2280183C Method of treating dry eye disease with purinergic receptor agonists
04/22/2008CA2279963C Dinucleotides and their use
04/22/2008CA2210031C Solid phase synthesis of oligonucleotides
04/17/2008WO2008045419A1 Preparation of nucleosides ribofuranosyl pyrimidines
04/17/2008WO2008043704A1 Hcv nucleoside inhibitor
04/17/2008WO2008043426A2 Components and method for enzymatic synthesis of nucleic acids
04/17/2008WO2008000745A3 Adenosine derivatives for the treatment of pain
04/17/2008US20080090844 Infections caused by adenovirus, cytomegalovirus, hepatitis A virus (HAV), hepatitis B virus (HBV), flaviviruses including Yellow Fever virus, herpes virus; Immunomodulators; antiviral and antitumor agents; modulation of cytokine receptors; improved oral tolerability
04/17/2008US20080090774 Nucleoside compounds and their use for treating cancer and diseases associated with somatic mutations
04/16/2008EP1910575A2 Immunohistochemistry detection method
04/16/2008EP1910393A2 A novel process for the preparation of didanosine using novel intermediates
04/16/2008CN100381454C Crystalline form of a ribofuranosyluronamide derivative: a human adenosine a2a receptor agonist
04/15/2008US7358353 Expose cells to gene and nucleotide sequence that encodes T or B cell epitope; generates antibodies that bind specifically; immunogenic
04/15/2008US7358235 Nitrobenzylthioinosine compounds for relief of pain
04/10/2008WO2007121918A3 Use of 2-(purin-9-yl)-tetrahydofuran-3,4-diol derivatives as adenosine a2a receptor agonists
04/10/2008WO2007045998A3 New nucleic acid base pairs
04/10/2008WO2007015257A3 A process for the preparation of gemcitabine using novel intermediates
04/10/2008WO2007004230A3 A novel process for the preparation of didanosine using novel intermediates
04/10/2008US20080085871 Polysaccharide component protects the 5-FU from absorption in the upper gastrointestinal tract, delivers the 5-FU to the colorectal area
04/10/2008US20080085869 Sense strand, antisense strand having complementarity to both the sense strand and a target gene, forming a duplex, a conjugate, facilitating cellular delivery, and a linker molecule; facilitates delivery to a cell, tissue or organism
04/10/2008US20080085509 Single copy genomic hybridization probes and method of generating same
04/09/2008EP1907408A1 Stable nad/nadh derivatives
04/09/2008EP1907407A1 Improvements to analogous compounds of 6-thioguanosine triphosphate, their use in medical fields and processes for their preparation
04/09/2008CN101157712A Method for separating and purifying cordycepin
04/09/2008CN100379876C Analyte assay using particulate labels
04/09/2008CN100379750C Inhibitors of nucleoside phosphorylases and nucleosidases
04/09/2008CN100379709C Methods of producing phosphitylated compounds
04/08/2008US7355037 Thermolabile hydroxyl protecting groups and methods of use
04/08/2008US7355036 Two-stage protective groups for the synthesis of biopolymers
04/08/2008US7354906 Composition of anti-HIV drugs and anti-cortisol compounds and method for decreasing the side effects of anti-HIV drugs in a human
04/08/2008US7354615 precipitating mixed crystals by adding an aqueous mixed solution of disodium 5'-guanylate and disodium 5'-inosinate and a hydrophilic organic solvent at the same time into a crystallization vessel
04/08/2008CA2271126C Method of treating bronchitis with uridine triphosphates and related compounds
04/03/2008WO2008038094A2 Process for the preparation of pure adenosine
04/03/2008WO2007110624A3 Immobilised reagent
04/02/2008EP1905829A2 Templated molecules and methods for using such molecules
04/02/2008EP1905778A2 Novel 2'-C-methyl nucleoside derivatives
04/02/2008EP1904512A1 Purine derivatives as agonists of the adenosine a2a receptor
04/02/2008EP1904511A2 Homogemcitabines
04/02/2008EP1660510B1 Avermectins and avermectin monosaccharides substituted in the 4'- and 4'' position having pesticidal properties
04/02/2008EP1210357B1 Oligonucleotide n3'-p5' thiophosphoramidates: their synthesis and use
04/02/2008CN101153049A Method of producing high purity clofarabine
04/01/2008US7351863 Method of fluorination
04/01/2008US7351399 Conversion by human liver microsomes to MPO3H2; hepatitis, cancer, liver fibrosis, malaria, other viral and parasitic infections, and metabolic diseases where the liver is responsible for the overproduction of the biochemical end product, diabetes; enhanced oral drug delivery
03/2008
03/27/2008WO2008036841A2 Tripartite oligonucleotide complexes and methods for gene silencing by rna interference
03/27/2008WO2008036825A2 Duplex oligonucleotide complexes and methods for gene silencing by rna interference
03/27/2008WO2008016906A3 3'-phosphate-labeled nucleotide analogs and their use for sequencing a nucleic acid
03/27/2008US20080076913 Nucleosides; sodium/lithium/potassium peroxides as nucleophilic agents; solid phase synthesis
03/27/2008US20080076793 Use of an ascomycin for the treatment of blepharitis
03/26/2008EP1196396B1 Pharmacologically active compounds with two covalently linked active principles (sodium channnel blocker/p2y2 receptor agonist) for the treatment of mucosal surfaces
03/26/2008CN101148465A 3-Benzyl-L-uridine and preparation method thereof
03/26/2008CN100376593C Crystalline and amorphous forms of beta-l-2'-deoxythymidine
1 ... 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 ... 201